Nxera Pharma
4565.T
4,66 €
Share price
9.46%
Change (1 day)
-52.59%
Change (1 year)
Categories
EPS for Nxera Pharma (4565.T)
EPS in 2024 (TTM): -0,75 €
According to Nxera Pharma's latest financial reports the company's current EPS (TTM) is -0,72 €. In 2023 the company made an earnings per share (EPS) of -0,56 € a decrease over its 2022 EPS that were of 0,03254 €.
EPS history for Nxera Pharma from 2005 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 (TTM) | -0,75 € | 32.41% |
| 2023 | -0,56 € | -1829.25% |
| 2022 | 0,03254 € | -67.15% |
| 2021 | 0,09907 € | -40.17% |
| 2020 | 0,17 € | 5.97% |
| 2019 | 0,16 € | -124.17% |
| 2018 | -0,65 € | -157.64% |
| 2017 | 1,12 € | -691.98% |
| 2016 | -0,19 € | -366.52% |
| 2015 | 0,07109 € | -74.61% |
| 2014 | 0,28 € | 45.12% |
| 2013 | 0,19 € | -142.56% |
| 2012 | -0,45 € | 4.42% |
| 2011 | -0,43 € | 18.94% |
| 2010 | -0,36 € | -52.47% |
| 2009 | -0,77 € | -161% |
| 2008 | 1,26 € | -205.26% |
| 2007 | -1,20 € | 23.33% |
| 2006 | -0,97 € | 42.13% |
| 2005 | -0,68 € |